Expression of CD44 in duct cell carcinomas and in intraductal neoplasms of the pancreas

Anticancer Research

Volumn 17, Issue 1 A, 1997, Pages 215-219

  Satoh, Kennichi ^a   Shimosegawa, Tooru ^a   Koizumi, Masaru ^a   Toyota, Takayoshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer; CD44; Human; Intraductal neoplasm; Pancreas

Indexed keywords

HERMES ANTIGEN; MONOCLONAL ANTIBODY;

ALTERNATIVE RNA SPLICING; ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PANCREAS DUCT; PRIORITY JOURNAL;

ANTIGENS, CD44; CARCINOMA, DUCTAL, BREAST; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS;

EID: 0031052954     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hanes BF, Telen MD, Hale LP, Denning SM: CD44-A molecule involved in leukocyte adherence and T-cell activation. Immunology Today 10: 10423-10428, 1989.
2. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JE: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89: 12160-12164, 1992.
3. Screaton GR, Bell MV, Bell JI, Jackson DG: The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat. J Biol Chem 268: 12235-12238, 1993.
4. Matsumura Y and Tarin D: Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340: 1053-1058, 1992.
5. Heider KD, Dammrich J, Skroch-Angel P, Muller-Hermelink HK, Vollmers HP, Herrlich P, Ponta H: Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res 53: 4197-4203, 1993.
6. Wielenga VJM, Heider KH, Offerhaus GJA, Adolf GR, van den Berg FM, Ponta H, Herrlich P, Pals ST: Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53: 4754-4756, 1993.
7. Heider KH, Hofmann M, Hors E, van den Berg F, Ponta H, Herrlich P, Pals ST: A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 120: 227-233, 1993.
8. Rall CJN and Rustgi AK: CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma. Cancer Res 55: 1831-1835, 1995.
9. Günthert U, Hofmann M, Ruby W, Rober S, Zöller M, Haußmann I, Matzku S, Wenzel A, Ponta H, Herrlich, P: A new variant glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13-24, 1991.
10. Klöppel G: Pathology of nonendocrine pancreatic tumors. In: The Pancreas: biology, pathobiology, and disease. (Ed.:Go VLW), 2nd ed. Raven Press, Now York, U.S.A. 1993. pp.:891-897.
11. Lamnkin HA, Mothersill CM, Kelehan P: Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection. J Pathol 172: 13-18, 1994.
12. Takada M, Yamamoto Y, Saitoh Y: The significance of CD44 in human pancreatic cancer: I. High expression of CD44 in human pancreatic adenocarcinoma. Pancreas, 9: 748-752, 1994.
13. Takada M, Yamamoto Y, Saitoh Y: The significance of CD44 in human pancreatic cancer: II. The role of CD44 in human pancreatic adenocarcinoma invasion. Pancreas 9: 753-757, 1994.
14. Koopman G, Heider KH, Horst E, Adolf GR, van den Berg F, Ponta H, Herrlich P, Pals ST: Activated human lymphocytes and aggressive non-hodgkin's lymphomas express a homologue of the rat metastasis - associated variant of CD44. J Exp Med 177: 897-904, 1993.
15. Herrlich P, Zöller M, Pals ST, Ponta H: CD44 splice variants: metastases meet lymphocytes. Immunology Tody 14: 395-399, 1993.
16. Satoh K, Shimosegawa T, Moriizumi S, Koizumi M, Toyota T: K-ras mutation and p53 protein accumulation in intraductal mucin-hypersecreting neoplasms of the pancreas. Pancreas 12: 362-368, 1996.
17. Satoh K, Sasano H, Shimosegawa T, Koizumi M, Yamazaki T, Mochizuki F, Kobayashi N, Okano T, Toyota T, Sawai T: An immunohistochemical study of c-erbB-2 oncogene product in intraductal mucin-hypersecreting neoplasms and in ductal cell carcinoma of the pancreas. Cancer 72: 51-56, 1993.
18. Satoh K, Ohtani H, Shimosegawa T, Koizumi M, Sawai T Toyota T: Infrequent stromal expression of gelatinase A and intact basement membrane in intraductal neoplasms of the pancreas. Gestroenterology 107: 1488-1495, 1994.